Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
Aim. Nature development of lymphoma associates with increased risk of cardiovascular diseases. We aimed to evaluate the prognostic value of circulating NT-proBNP, galectin-3, and VE-cadherin in survivors of Hodgkin lymphoma. Methods: Surveys were given to Hodgkin lymphoma survivors who reached at li...
Saved in:
Main Author: | B. B. Samura (Author) |
---|---|
Format: | Book |
Published: |
Zaporozhye State Medical University,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015) -
Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017) -
Quality of life among patients after Hodgkin lymphoma treatment: a 3-year prospective study
by: B. B. Samura
Published: (2017) -
Circulating sST2 and prognosis of cardiovascular events in remission of multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022) -
Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar
by: Christos Sachpekidis, et al.
Published: (2019)